Screener
ADMA Biologics ADMA Gain (loss) on disposal of assets
Gain (loss) on disposal of assets at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by ADMA Biologics in its filing.
Tagged under the XBRL concept us-gaap:GainLossOnDispositionOfAssets.
The source filing: ADMA Biologics’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 5:16 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001140361-26-019336
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| cash provided by operating activities: | ||
| Depreciation and amortization | 1,839 | 1,969 |
| Gain on sale of plasma centers | (7,980) | - |
| Loss on disposal of fixed assets | 42 | - |
| Deferred income tax provision | 3,292 | 3,425 |
| Stock-based compensation | 6,329 | 4,624 |
| Amortization of debt discount | 191 | 190 |
| Amortization of license revenue | (36) | (36) |
Item 1.
FAQ
- What is ADMA Biologics's gain (loss) on disposal of assets?
- ADMA Biologics (ADMA) reported gain (loss) on disposal of assets of -$42K in Q1 2026.
- What is the long-term trend for ADMA Biologics's gain (loss) on disposal of assets?
- Over 2 years (2023 to 2025), ADMA Biologics's gain (loss) on disposal of assets has grown at a -77.8% compound annual growth rate (CAGR), from -$182K to -$9K.
- What does gain (loss) on disposal of assets mean?
- Gains or losses recognized on the disposal of businesses, property, equipment, investments, or other assets at prices above or below their carrying value.
Ask your AI about ADMA Biologics's gain (loss) on disposal of assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude